Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 190
Selected: 0
NCT IDTitle
NCT03096093Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
NCT06975579The COherence of Scatter Identification and Exclusion Algorithm Study
NCT07529418The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
NCT07098819The eValuation of Sources of vIBRAtioN for Vibrational Shear Wave elasTography
NCT07741929Patient and Provider Perspectives on Genetic Risk Profiling
NCT06868355APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials
NCT02126800Rapid Medical Donation Programme for Breast Cancer
NCT02070120Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer
NCT06976892Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
NCT05840549A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement
NCT03740893PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
NCT02170415Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery
NCT00199901Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma
NCT02503917Gynaecologic Organ Segmentation and Motion Tracking Using Ultrasound
NCT00140582Primary Rituximab and Maintenance
NCT01460693Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
NCT02525068A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC
NCT04763317Precision Medicine in the Prostate Cancer Care Pathway
NCT00959023Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
NCT02388308Evaluation of Clarity Ultrasound Guidance for Prostate Therapy
NCT03466034The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT05741801Digital Alerts for Sepsis: a Qualitative Study
NCT02389842PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
NCT06470685Prophylactic Prostatectomy for Prostate Cancer (PPPC)
NCT02437227Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
NCT00787514FR in Stored Plasma
NCT01658930Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
NCT03809377Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
NCT00692354Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
NCT04458311Abiraterone Acetate in Combination With Tildrakizumab
NCT03327662Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer
NCT01101438A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
NCT02955082The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
NCT05968417Myeloma Novel Drug Discovery Ver 1.2
NCT0024852117-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery
NCT07737509Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample Analysis
NCT00392535Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00499174Observation or Radical Treatment in Patients With Prostate Cancer
NCT05581121PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT04802590Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
NCT01726374Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours
NCT04686188Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT01682772TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer
NCT04584853PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
NCT011246823-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT01505829Diffusion-weighted Imaging Study in Cancer of the Ovary